)
Edge20 Mar 2026
Tetra Pak: The Shape of Innovation
The story of Tetra Pak, the Rausing family, and how a paper tetrahedron gave rise to a company that now delivers almost 180 billion packages a year.
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical (RARE) investor relations material
Ultragenyx Pharmaceutical Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy filing summary27 Mar, 2026
Executive summary
Annual meeting scheduled for May 14, 2026, to be held virtually for shareholder participation.
Shareholders are encouraged to review proxy materials and annual report before voting.
Voting matters and shareholder proposals
Election of three directors: Emil D. Kakkis, M.D., Ph.D., Shehnaaz Suliman, M.D., and Daniel G. Welch, all recommended by the board.
Approval sought for the Third Amended and Restated 2023 Incentive Plan.
Ratification of Ernst & Young LLP as independent auditor for fiscal year ending December 31, 2026.
Advisory vote on executive compensation (say-on-pay) included.
Board of directors and corporate governance
Board recommends all director nominees for election at the annual meeting.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Ultragenyx Pharmaceutical
- Proxy covers director elections, incentive plan, auditor ratification, and executive pay, with strong governance focus.RARE
Proxy filing27 Mar 2026 - Pipeline advances and regulatory milestones drive growth, with pivotal data and approvals expected soon.RARELeerink Global Healthcare Conference 202611 Mar 2026
- Pivotal Angelman phase III data and key gene therapy approvals expected this year.RAREBarclays 28th Annual Global Healthcare Conference10 Mar 2026
- Angelman, bone, and gene therapy programs advance with pivotal data and regulatory milestones ahead.RARETD Cowen 46th Annual Health Care Conference2 Mar 2026
- Revenue growth and late-stage pipeline drive path to profitability and new approvals in 2026.RARECorporate presentation13 Feb 2026
- 2025 revenue up 20% to $673M; restructuring targets 2027 profitability and new launches.RAREQ4 202513 Feb 2026
- All proposals, including board elections and incentive plan approval, were passed.RAREAGM 20243 Feb 2026
- Q2 revenue up 36% to $147M; 2024 guidance raised on strong demand and clinical progress.RAREQ2 20242 Feb 2026
- Multiple late-stage programs and global launches drive growth and profitability by 2026.RAREGoldman Sachs 45th Annual Global Healthcare Conference1 Feb 2026
Next Ultragenyx Pharmaceutical earnings date
Q1 20265 May, 2026
Ultragenyx Pharmaceutical
Next Ultragenyx Pharmaceutical earnings date
Q1 20265 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage